Filing Details

Accession Number:
0000899243-22-014796
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-14 16:14:26
Reporting Period:
2022-04-12
Accepted Time:
2022-04-14 16:14:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1327273 Lyra Therapeutics Inc. LYRA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1138399 North Bridge Venture Partners V-B Lp 60 William Street, Suite 350
Wellesley MA 02481
No No Yes No
1138402 North Bridge Venture Partners V A Lp 60 William Street, Suite 350
Wellesley MA 02481
No No Yes No
1206641 A Richard Damore 60 William Street, Suite 350
Wellesley MA 02481
No No Yes No
1297397 North Bridge Venture Management V, L.p. 60 William Street, Suite 350
Wellesley MA 02481
No No Yes No
1327539 P L Vi Partners Venture Bridge North 60 William Street, Suite 350
Wellesley MA 02481
No No Yes No
1401650 Nbvm Gp, Llc 60 William Street, Suite 350
Wellesley MA 02481
No No Yes No
1590898 North Bridge Venture Management Vi, L.p. 60 William Street, Suite 350
Wellesley MA 02481
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-12 1,076,851 $4.22 1,855,443 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-04-12 527,806 $4.22 909,424 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-04-12 765,010 $4.22 1,318,133 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. The reportable securities were acquired pursuant to the Securities Purchase Agreement dated April 7, 2022 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors.
  2. The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  3. The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  4. The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.